DNA based customized nutraceutical "gene therapy" utilizing a genoscore: A hypothesized paradigm shift of a novel approach to the diagnosis, stratification, prognosis and treatment of inflammatory processes in the human

Medical Hypotheses

Volumn 66, Issue 5, 2006, Pages 1008-1018

  Blum, Kenneth ^a,b   Meshkin, Brian ^b   Downs, B William ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Salugen Inc   (United States)

^c Allied Nutraceutical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; AMPHETAMINE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CELECOXIB; CHONDROITIN SULFATE; COCAINE; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DIAMORPHINE; DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GANODERMA LUCIDUM EXTRACT; GLUCOSAMINE SULFATE; HERBACEOUS AGENT; HOMEOPATHIC AGENT; HYDROCODONE; IBUPROFEN; MINERAL; MORPHINE; NAPROXEN; NUTRACEUTICAL; OPIATE; PARACETAMOL; PSYCHOSTIMULANT AGENT; RACLOPRIDE; ROFECOXIB; UNINDEXED DRUG; VALDECOXIB; VITAMIN;

ANALGESIA; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CARDIOVASCULAR DISEASE; CHRONIC PAIN; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIET SUPPLEMENTATION; DISEASE CLASSIFICATION; DOPAMINE RELEASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DYSPEPSIA; FATIGUE; FIBROMYALGIA; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENOTYPE; GOUT; HEALTH CARE COST; HUMAN; INFLAMMATORY DISEASE; JUVENILE RHEUMATOID ARTHRITIS; LIMBIC CORTEX; NEUROCHEMISTRY; NOCICEPTION; NONHUMAN; NUCLEUS ACCUMBENS; NUTRIGENOMICS; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REWARD; RHEUMATOID ARTHRITIS; SCLERODERMA; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

DIETARY SUPPLEMENTS; GENE EXPRESSION PROFILING; GENE THERAPY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEALTH STATUS INDICATORS; HUMANS; INFLAMMATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACOGENETICS; PROGNOSIS; PROTEOME;

GANODERMA LUCIDUM;

EID: 32144455935     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.09.029     Document Type: Article

References (59)

1. Decision Resources, OA Report 2003.
2. President Loses Ground Going into 2004 races, The Orlando Sentinel, 12/22/2003.
3. Term coined by Dr. Nicholas Dinublie, an orthopedic surgeon at the hospital of the University of Pennsylvania, 1999.
4. D.H. Solomon, J.N. Katz, J.P. Jacobs, A.M. La Tourette, and J. Coblyn Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice Arthritis Rheum 46 12 2002 3136 3142
5. W. Holden, J. Joseph, and L. Williamson Use of herbal remedies and potential drug interactions in rheumatology outpatients Ann Rheum Dis 64 5 2005 790
6. M. Guenot, J. Bullier, J.-P. Rospars, P. Lansky, Mertens, and M. Sindou Single-unit analysis of the spinal dorsal horn in patients with neuropathic pain J Clin Neurochem 20 2003 143 150
7. S. Dalal, and R. Melzack Potentiation of opioid analgesia by psychostimulant drugs: a review J Pain Symp Man 16 1998 245 253
8. A. Reinert, R. Treede, and B. Bromm The pain inhibiting pain effect: an electrophysiological study in humans Brain Res 862 2000 103 110
9. N. Altier, and J. Stewart The role of dopamine in the nucleus Accumbens in Analgesia Life Sci 65 1999 2269 2287
10. K.B.J. Franklin Analgesia and abuse potential: An accidental association or a common substrate? Pharmacol Biochem Behav 59 1998 993 1001
11. M.J. Morgan, and K.B.J. Franklin Dopamine receptor subtypes and formalin test analgesia Pharmacol Biochem Behav 40 1991 317 322
12. B.K. Taylor, C. Joshi, and H. Uppal Stimulation of Dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain Brain Res 98 2003 135 143
13. J.E. Magnusson, and R.V. Martin Additional evience for the involvement of the basal ganglia in formalin-induced nociception: the role of the nucleus accumbens Brain Res 942 2002 128 132
14. N. Hagelberg, H. Forssell, and S. Aalto Altered dopamine D2 receptor binding in atypical facial pain Pain 106 2003 43 48
15. K. Blum, and E.R. Braverman Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive and compulsive behaviors J Psychoactive Drugs 32 Suppl. 2000 1 100
16. M. Dziedzicka-Wasylewska, P. Willner, and M. Papp Changes in dopamine receptor mRNA expression following chronic and mild stress and chronic anti-depressant treatment Behav Pharmacol 8 6-7 1997 607 618
17. M.J. Kreek, and G. Koob Drug dependence: stress and dysregulation of brain reward pathways Drug Alcohol Depen 51 1998 23 47
18. De. Comings, Muhleman, and R. Gysin dopamine D2 Receptor (DRD@) gene and susceptibility to posttraumatic stress disorder: A study and replication Biol Psychiat 40 1995 368 372
19. A.Y. Deutch, and R.H. Roth The determinants of stress-induced activation of the prefrontal cortical dopamine system Prog Brain Res 85 1990 367 402
20. P.W. Kalivas, and R. Abhold Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine Brain Res 414 1987 339 348
21. N. Altier, and J. Stewart Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accimbens amphetamine J Pharamacol Exp Ther 285 1998 208 215
22. K. Blum, A.H. Briggs, and M.C. Trachtenberg Ethanol ingestive behavior as a function of central neurotransmission Experientia 45 1989 444 452
23. P.B. Wood Stress and Dopamine: implications for the pathophysiology of chronic widespread pain Med Hpotheses 62 2004 420 424
24. Y.L. Wu Psychological stress selectively increases extracellular dopamine on "shell", but not in the "core" of the rat nucleus accumbens: a novel dual-needle probe simultaneous microdialysis study Brain Res 275 1999 69 72
25. Va. Russell, M.C.L. Lanin, and J.F. Taljaard Effect of ethanol on 3H-dopamine release in rat nucleus accumbens and striatal slices Neurochem Res 13 1988 487 492
26. Legangneux Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H] imipramine reintake un the primary fibromyalgia syndrome Rheimatology (Oxford) 40 2001 290 296
27. P.W. Kallivas, and P. Duffy Selective activation of dopamine transmission in the shell of the nucleus acimbens by stress Brain Res 675 1995 325 328
28. L. Quintero Long-lasting delayed hyperalgesia after subchronic swim stress Pharmacol Biochem Behav 67 2000 449 458
29. C. Deal, and R. Moskowitz Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate Rheum Dis Clin North Am 25 1999 379 395
30. D.C. Miller, and J. Richardson Does glucosamine relieve arthritis joint pain J Fam Pract 52 2003 645 647
31. O. Bruyere, and A. Honore Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3 year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate Osteoarthr Cartilage 1 2003 1 5
32. G. Crolle, and E. D'Este Glucosamine sulfate for the management of arthrosis Curr Med Res Opin 7 1980 104 109
33. K. Pavelka, J. Gatterova, M. Olejarova, S. Machacek, G. Giacovelli, and L. Rovati Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study Arch Intern Med 162 2002 2113 2123
34. J. Reginster, R. Deroisy, and L. Rovati Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial Lancet 357 2001 251 256
35. P. Morreale, R. Manopulo, and M. Galati Comparison of the anti-inflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis J Rheumatol 23 1996 1835 1839
36. P. Bourgeois, G. Chales, J. Dehais, B. Delcambre, J. Kuntz, and S. Rozenberg Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate3 × 400 mg/day vs placebo Osteoarthr Cartilage 6 Suppl. A 1998 25 30
37. A.J. Matheson, and C.M. Perry Glucosamine: a review of its use in the management of osteoarthritis Drugs Aging 20 14 2003 1041 1060
38. H. Muller-Fassbender, G.L. Bach, W. Haase, L.C. Rovati, and I. Setnikar Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee Osteoarthr Cartilage 2 1 1994 61 69
39. B. Mazieres, B. Combe, A. Phan Van, J. Tondut, and M. Grynfeltt Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study J Rheumatol 28 1 2001 173 181
40. Abou-Raya S, Abou-Raya A. Assessment of clinically releveant changes in patients with knee Osteoarthritis treatment with a symptomatic sllow acting drug. European League Against Rheumatism (EULAR) meetings 2005 SAT0266.
41. Kamel M, Abbadi M. Glucosamine sulphate induces cartilage qualitative morphological changes in Osteoarthritis, and ultrasonographic and MRI evidence. European League Against Rheumatism (EULAR) meetings 2005 SAT0267.
42. S. de Pascual-Teresa, K.L. Johnston, M.S. DuPont, K.A. O'Leary, P.W. Needs, and L.M. Morgan Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo J Nutr 134 3 2004 552 557
43. K.J. Hong, D.M. Dunn, C.L. Shen, and B.C. Pence Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colonic carcinoma cells Phytother Res 18 9 2004 768 770
44. A.F. Walker, R. Bundy, and S.M. Hicks Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise health adults Phytomedicine 9 2002 681 686
45. A.L. Russell, and M.F. McCarty DL-phenylalanine markedly potentiates opiate analgesia - an example of nutrient/pharmaceutical up-regulation of the endogenous analgesia system Med Hypotheses 55 4 2000 283 288
46. K. Nakatani, N. Nakahata, T. Arakawa, H. Yasuda, and Y. Ohizumi Inhibition of cyclooxygenase and prostaglandin E2 synthesis by gamma-mangostin, a xanthone derivative in mangosteen, in C6 rat glioma cells Biochem Pharmacol 63 1 2002 73 79
47. S. Heux, F. Morin, R.A. Lea, M. Ovcaric, L. Tajouri, and L.R. Griffiths The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians Hypertens Res 27 9 2004 663 667
48. G.V. Dedoussis, D.B. Panagiotakos, C. Pitsavos, C. Chrysohoou, J. Skoumas, and D. Choumerianou An association between the methylenetetrahydrofolate reductase (MTHFR) C677T mutation and inflammation markers related to cardiovascular disease Int J Cardiol 100 3 2005 409 414
49. Miyaki K, Murata M, Kikuchi H, Takei I, Nakayama T, Watanabe K, et al. Assessment of tailor-made prevention of atherosclerosis with folic acid supplementation: randomized, double-blind, placebo-controlled trials in each MTHFR C677T genotype. J Hum Genet, in press.
50. B. Abrahamsen, J.S. Madsen, C.L. Tofteng, L. Stilgren, E.M. Bladbjerg, and S.R. Kristensen Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study Bone 36 3 2005 577 583
51. A. Coppen, and C. Bolander-Gouaille Treatment of depression: time to consider folic acid and vitamin B12 J Psychopharmacol 19 1 2005 59 65
52. J.P. Casas, L.E. Bautista, L. Smeeth, P. Sharma, and A.D. Hingorani Homocysteine and stroke: evidence on a causal link from mendelian randomisation Lancet 365 9455 2005 224 232
53. A.E. van Ede, R.F. Laan, H.J. Blom, T.W. Huizinga, C.J. Haagsma, and B.A. Giesendorf The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients Arthritis Rheum 44 11 2001 2525 2530
54. S. Kerlan-Candon, B. Combe, R. Vincent, J. Clot, V. Pinet, and J.F. Eliaou HLA-DRB1 gene transcripts in rheumatoid arthritis Clin Exp Immunol 124 1 2001 142 149
55. F.A. van Gaalen, J. van Aken, T.W. Huizinga, G.M. Schreuder, F.C. Breedveld, and E. Zanelli Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis Arthritis Rheum 50 7 2004 2113 2121
56. J.J. Goronzy, E.L. Matteson, J.W. Fulbright, K.J. Warrington, A. Chang-Miller, and G.G. Hunder Prognostic markers of radiographic progression in early rheumatoid arthritis Arthritis Rheum 50 1 2004 43 54
57. J.D. Gorman, E. David-Vaudey, M. Pai, R.F. Lum, and L.A. Criswell Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis Arthritis Rheum 50 2004 3476 3484
58. Kurt J. Doege, Silvija N. Coulter, Lauren M. Meek, Kirstin Maslen, and G. Jill Wood A human-specific polymorphism in the coding region of the aggrecan gene. Variable number of tandem repeats produce a range of core protein sizes in the general population J Boil Chem 272 1997 13974 13979
59. D. Bagchi, B. Misner, M. Bagchi, S.C. Kothari, B.W. Downs, and R.D. Fafard Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration Int J Clin Pharmacol Res 22 3-4 2002 101 110